The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
Tsuprykov O, Ando R, Reichetzeder C, von Websky K, Antonenko V, Sharkovska Y, Chaykovska L, Rahnenführer J, Hasan AA, Tammen H, Alter M, Klein T, Ueda S, Yamagishi SI, Okuda S, Hocher B.
Tsuprykov O, et al. Among authors: von websky k.
Kidney Int. 2016 May;89(5):1049-1061. doi: 10.1016/j.kint.2016.01.016. Epub 2016 Mar 24.
Kidney Int. 2016.
PMID: 27083282
Free article.